TW200612903A - Use of trisubstituted benzopyranones - Google Patents

Use of trisubstituted benzopyranones

Info

Publication number: TW200612903A
Authority: TW; Taiwan
Prior art keywords: benzopyranones; trisubstituted; present; trisubstituted benzopyranones; relates
Prior art date: 2004-07-05

Application number

TW094119109A

Other languages

English (en)

Inventor

Stefan Germer

Hermann Hauer

Egon Koch

Karl Schotz

Original Assignee

Bioplanta Arzneimittel Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-05

Filing date

2005-06-09

Publication date

2006-05-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35612964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200612903(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-09 Application filed by Bioplanta Arzneimittel Gmbh filed Critical Bioplanta Arzneimittel Gmbh

2006-05-01 Publication of TW200612903A publication Critical patent/TW200612903A/zh

Links

ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title abstract 3
206010061218 Inflammation Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
239000000419 plant extract Substances 0.000 abstract 1
230000011506 response to oxidative stress Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Botany (AREA)
Tropical Medicine & Parasitology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Obesity (AREA)
AIDS & HIV (AREA)
Hospice & Palliative Care (AREA)

TW094119109A 2004-07-05 2005-06-09 Use of trisubstituted benzopyranones TW200612903A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004032440A DE102004032440B4 (de)	2004-07-05	2004-07-05	Verwendung von trisubstituierten Benzopyranonen

Publications (1)

Publication Number	Publication Date
TW200612903A true TW200612903A (en)	2006-05-01

Family

ID=35612964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094119109A TW200612903A (en)	2004-07-05	2005-06-09	Use of trisubstituted benzopyranones

Country Status (24)

Country	Link
US (1)	US20080020068A1 (zh)
EP (1)	EP1763520B1 (zh)
JP (1)	JP2008505064A (zh)
KR (1)	KR20070038988A (zh)
CN (1)	CN101044132A (zh)
AR (1)	AR050908A1 (zh)
AT (1)	ATE417842T1 (zh)
AU (1)	AU2005259420A1 (zh)
BR (1)	BRPI0513017A (zh)
CA (1)	CA2570908A1 (zh)
DE (3)	DE102004032440B4 (zh)
DK (1)	DK1763520T3 (zh)
ES (1)	ES2317258T3 (zh)
GT (1)	GT200500182A (zh)
MX (1)	MXPA06014844A (zh)
PA (1)	PA8638301A1 (zh)
PE (1)	PE20060528A1 (zh)
PL (1)	PL1763520T3 (zh)
PT (1)	PT1763520E (zh)
RU (1)	RU2383537C2 (zh)
TW (1)	TW200612903A (zh)
UA (1)	UA88165C2 (zh)
UY (1)	UY28976A1 (zh)
WO (1)	WO2006002918A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1847236B (zh) *	2006-05-16	2011-03-23	吉林省西点药业科技发展股份有限公司	7,8-二羟基-2-氧代-2h-苯并吡喃类衍生物及合成方法和医药用途
ATE471158T1 (de)	2007-04-17	2010-07-15	Schwabe Willmar Gmbh & Co	Verfahren zur herstellung von lagerstabilen lösungen aus pelargonium-extrakten
CA2682894C (en) *	2007-04-17	2016-01-19	Dr. Willmar Schwabe Gmbh & Co. Kg	Dry extracts from pelargonium sidoides and pelargonium reniforme
WO2008128344A1 (en) *	2007-04-18	2008-10-30	The University Of British Columbia	Small-molecule hepatitis c virus (hcv) ns3/4a serine protease inhibitors
KR100896453B1 (ko) *	2007-07-18	2009-05-14	닥터 빌마르 쉬바베 게엠바하 운트 코 카게	페라고늄 시도이데스 시럽
AU2011239432A1 (en) *	2010-04-16	2012-10-25	Colby Pharmaceutical Company	Androgen induced oxidative stress inhibitors
TWI583677B (zh) *	2012-09-21	2017-05-21	日本臟器製藥股份有限公司	香豆素衍生物
JP6089055B2 (ja) *	2014-03-20	2017-03-01	日本臓器製薬株式会社	クマリン誘導体を含有する医薬
CN106232116B (zh) *	2014-03-20	2020-05-01	日本脏器制药株式会社	含有香豆素衍生物作为有效成分的治疗或预防剂
CN104974122B (zh) *	2015-07-02	2017-03-22	云南中烟工业有限责任公司	一种源自烟草的香豆素化合物、其制备方法和用途
CN105461676B (zh) *	2015-11-20	2017-12-12	上海秉丰生物科技有限公司	一种伪麻黄碱类衍生物及其制备方法与应用
JP6952350B2 (ja) *	2016-06-10	2021-10-20	国立大学法人東北大学	インスリン分泌促進剤又はインスリン抵抗性改善剤
CN111803492B (zh) *	2020-08-05	2022-03-29	苏州大学	一种香豆素类化合物在制备治疗乙肝药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4111861A1 (de) *	1991-04-11	1992-10-15	Schwabe Willmar Gmbh & Co	Benzopyranone, verfahren zu ihrer herstellung und verwendung
DE4323409A1 (de) *	1993-07-13	1995-01-19	Boehringer Mannheim Gmbh	Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
DE4337906A1 (de) *	1993-11-08	1995-05-11	Cassella Ag	Verwendung von Cumarinderivaten
HRP970529B1 (en) *	1997-10-02	2003-06-30	Pliva Pharm & Chem Works	Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof
EP1104672A1 (de) *	1999-12-02	2001-06-06	Laboratoires Serobiologiques(Societe Anonyme)	Kosmetische und/oder pharmazeutische Zubereitungen
US20030175777A1 (en) *	2002-02-04	2003-09-18	Bonagura Vincent R.	Eleutherosides as adjuncts for vaccines and immune modulation

2004
- 2004-07-05 DE DE102004032440A patent/DE102004032440B4/de not_active Withdrawn - After Issue
- 2004-07-05 DE DE102004063910A patent/DE102004063910B4/de not_active Withdrawn - After Issue
2005
- 2005-06-09 TW TW094119109A patent/TW200612903A/zh unknown
- 2005-06-21 UY UY28976A patent/UY28976A1/es unknown
- 2005-06-30 PL PL05756337T patent/PL1763520T3/pl unknown
- 2005-06-30 EP EP05756337A patent/EP1763520B1/de not_active Revoked
- 2005-06-30 CN CNA2005800224393A patent/CN101044132A/zh active Pending
- 2005-06-30 US US11/631,393 patent/US20080020068A1/en not_active Abandoned
- 2005-06-30 JP JP2007518536A patent/JP2008505064A/ja not_active Withdrawn
- 2005-06-30 AT AT05756337T patent/ATE417842T1/de active
- 2005-06-30 AU AU2005259420A patent/AU2005259420A1/en not_active Abandoned
- 2005-06-30 WO PCT/EP2005/007051 patent/WO2006002918A2/de active Application Filing
- 2005-06-30 RU RU2007104244/04A patent/RU2383537C2/ru not_active IP Right Cessation
- 2005-06-30 DK DK05756337T patent/DK1763520T3/da active
- 2005-06-30 ES ES05756337T patent/ES2317258T3/es active Active
- 2005-06-30 CA CA002570908A patent/CA2570908A1/en not_active Abandoned
- 2005-06-30 BR BRPI0513017-4A patent/BRPI0513017A/pt not_active IP Right Cessation
- 2005-06-30 UA UAA200612964A patent/UA88165C2/ru unknown
- 2005-06-30 KR KR1020067027823A patent/KR20070038988A/ko not_active Ceased
- 2005-06-30 PT PT05756337T patent/PT1763520E/pt unknown
- 2005-06-30 MX MXPA06014844A patent/MXPA06014844A/es active IP Right Grant
- 2005-06-30 DE DE502005006286T patent/DE502005006286D1/de not_active Revoked
- 2005-07-01 GT GT200500182A patent/GT200500182A/es unknown
- 2005-07-04 AR ARP050102782A patent/AR050908A1/es unknown
- 2005-07-04 PA PA20058638301A patent/PA8638301A1/es unknown
- 2005-07-05 PE PE2005000781A patent/PE20060528A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
DK1763520T3 (da)	2009-02-09
RU2383537C2 (ru)	2010-03-10
WO2006002918A2 (de)	2006-01-12
CA2570908A1 (en)	2006-01-12
PA8638301A1 (es)	2006-03-24
WO2006002918A3 (de)	2006-05-04
US20080020068A1 (en)	2008-01-24
EP1763520B1 (de)	2008-12-17
ES2317258T3 (es)	2009-04-16
RU2007104244A (ru)	2008-08-10
EP1763520A2 (de)	2007-03-21
UY28976A1 (es)	2006-02-24
DE502005006286D1 (de)	2009-01-29
DE102004063910B4 (de)	2006-12-28
JP2008505064A (ja)	2008-02-21
BRPI0513017A (pt)	2008-04-22
PL1763520T3 (pl)	2009-06-30
PT1763520E (pt)	2009-03-23
AR050908A1 (es)	2006-12-06
ATE417842T1 (de)	2009-01-15
DE102004032440B4 (de)	2007-02-08
UA88165C2 (en)	2009-09-25
DE102004063910A1 (de)	2006-02-09
GT200500182A (es)	2006-03-17
KR20070038988A (ko)	2007-04-11
CN101044132A (zh)	2007-09-26
PE20060528A1 (es)	2006-07-27
MXPA06014844A (es)	2007-03-26
AU2005259420A1 (en)	2006-01-12
DE102004032440A1 (de)	2006-02-16

Publication	Publication Date	Title
MY140826A (en)	2010-01-29	Substituted pyrazoline compounds, their preparation and use as medicaments.
WO2006072589A3 (en)	2006-10-12	Disubstituted ureas as kinase inhibitors
EP2305640A3 (en)	2011-07-20	Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
TW200716661A (en)	2007-05-01	A novel triterpenic acid derivative and the skin external preparation containing the same
MY148723A (en)	2013-05-31	Use of pinolenic acid for the treatment of obesity
MY147503A (en)	2012-12-14	Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
TW200608979A (en)	2006-03-16	Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200745043A (en)	2007-12-16	Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008087367A3 (fr)	2008-11-06	Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
UA104988C2 (uk)	2014-04-10	Похідні піроніндолу та спосіб їх отримання
TW200738699A (en)	2007-10-16	4-Substituted pyrazoline compounds, their preparation and use as medicaments
TW200612903A (en)	2006-05-01	Use of trisubstituted benzopyranones
MX2009008084A (es)	2009-10-12	Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
MXPA05013645A (es)	2006-02-24	Nuevos compuestos moduladores de los receptores de tipo ppar gama y su utilizacion en composiciones cosmeticas o farmaceuticas.
TW200621765A (en)	2006-07-01	Substituted phenylaminothiazoles and their use
SI1778680T1 (sl)	2009-02-28	Spirociklični cikloheksanski derivati
SI1594885T1 (sl)	2009-06-30	Zdravilo za inhibiranje rasti tumorjev
WO2009130422A3 (fr)	2009-12-30	N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
TW200510352A (en)	2005-03-16	Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
TW200745042A (en)	2007-12-16	Substituted pyrazoline compounds, their preparation and use as medicaments
MX2009012712A (es)	2009-12-08	Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
TW200505830A (en)	2005-02-16	Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
MX2009012714A (es)	2009-12-08	Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
TW200734335A (en)	2007-09-16	Compounds
WO2006103119A3 (en)	2007-02-15	Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics